The emerging extrahepatic manifestations of hepatitis C virus infection in chronic hepatitis and mixed cryoglobulinemia

Hepatitis Monthly

Volumn 8, Issue 3, 2008, Pages 207-211

  Fallahi, Poupak ^a   Ferri, Clodoveo ^b   Ferrari, Silvia Martina ^a   Pampana, Alessandro ^a   Sansonno, Domenico ^c   Antonelli, Alessandro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Atherosclerosis; Cardiopathy; Cryoglobulinemia; Diabetes; Hepatitis C; Hypothyroidism; Th1 Immunity; Thyroid autoantibodies; Thyroid autoimmunity; Thyroid cancer

Indexed keywords

AUTOANTIBODY; CRYOGLOBULIN; HEPATITIS C ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID PEROXIDASE ANTIBODY;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNE THYROIDITIS; CAROTID ARTERY OBSTRUCTION; CELLULAR IMMUNITY; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CRYOGLOBULINEMIA; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTHESIS; HYPOTHYROIDISM; IMMUNOPATHOGENESIS; MEDICAL LITERATURE; MYOCARDITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYARTHRITIS; PREVALENCE; REVIEW; RISK FACTOR; SJOEGREN SYNDROME; SYSTOLIC BLOOD PRESSURE; TH1 CELL; THYROID CANCER; THYROID DISEASE;

EID: 56149089566     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991; 9: 621-4.
2. Ferri C, Monti M, La Civita L, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-4.
3. Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006; 18: 54-63.
4. Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355-74.
5. Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998; 7: 275-9.
6. Ferri C, La Civita L, Longombardo G, et al. Hepatitis C virus in mixed cryoglobulinemia and B cell lymphoma. Clin Exp Rheumatol 1994; 12: 89-90.
7. Ferri C, La Civita L, Monti M, et al. Chronic hepatitis C and B-cell non-Hodgkin's lymphoma. QJM 1996; 89: 117-22.
8. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-4.
9. Ferri C, Antonelli A, Mascia MT, et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev 2007; 7: 114-20.
10. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 2007; 39: 2-17.
11. Fadda P, La Civita L, Zignego AL, Ferri C. Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome (in Italian). Reumatismo 2002; 54: 316-23.
12. Antonelli A, Ferri C, Fallahi P, et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 2006; 16: 563-72.
13. Antonelli A, Ferri C, Fallahi P, et al. Extrahepatic manifestations of hepatitis C virus: the thyroid disorders (in Italian). Recenti Prog Med 2005; 96: 370-81.
14. Antonelli A, Ferri C, Fallahi P, et al. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine 2008; 42: 137-43.
15. Antonelli A, Ferri C, Fallahi P, et al. Thyroid Cancer in HCV-Related Chronic Hepatitis Patients: A Case-Control Study. Thyroid 2007; 17: 447-51.
16. Antonelli A, Ferri C, Fallahi P, Nesti C, Zignego AL, Maccheroni M. Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin Exp Rheumatol 2002; 20: 693-6.
17. Antonelli A, Ferri C, Fallahi P. Thyroid cancer in patients with hepatitis C infection. JAMA 1999; 281: 1588.
18. Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117: 10-3.
19. Antonelli A, Ferri C, Fallahi P, et al. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 2004; 97: 499-506.
20. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 2010-7.
21. Noto H, Raskin P. Hepatitis C infection and diabetes. J Diabetes Complications 2006; 20: 113-20.
22. Costa LM, Mussi AD, Brianeze MR, Souto FJ. Hepatitis C as a risk factor for diabetes type 2: lack of evidence in a hospital in central-west Brazil. Braz J Infect Dis 2008; 12: 24-6.
23. Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, et al. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients. World J Gastroenterol 2007; 13: 6518-28.
24. Antonelli A, Ferri C, Fallahi P, et al. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology 2004; 43: 238-40.
25. Antonelli A, Ferri C, Fallahi P, et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2005; 28: 2548-50.
26. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
27. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Hepatology 2001; 33: 1554.
28. Alsatie M, Pandya F, Chalasani NP. Insulin resistance, hepatitis C, and liver transplantation. Liver Transpl 2008; 14: 136-7.
29. Masini M, Campani D, Boggi U, et al. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care 2005; 28: 940-1.
30. Gale EA. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 2005; 48: 2195-9.
31. Skowronski M, Zozulinska D, Juszczyk J, Wierusz-Wysocka B. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2006; 29: 750; author reply 751.
32. Antonelli A, Tuomi T, Nannipieri M, et al. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 2002; 45: 1298-306.
33. Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002; 359: 133-5.
34. Ishizaka Y, Ishizaka N, Takahashi E, et al. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 2003; 67: 26-30.
35. Haji SA, Starling RC, Avery RK, et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 2004; 23: 277-83.
36. Boddi M, Abbate R, Chellini B, et al. HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. Dig Liver Dis 2007; 39: S55-60.
37. Volzke H, Schwahn C, Wolff B, et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 2004; 174: 99-103.
38. Moritani M, Adachi K, Arima N, et al. A study of arteriosclerosis in healthy subjects with HBV and HCV infection. J Gastroenterol 2005; 40: 1049-53.
39. Matsumori A, Ohashi N, Hasegawa K, et al. Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Jpn Circ J 1998; 62: 389-91.
40. Okabe M, Fukuda K, Arakawa K, Kikuchi M. Chronic variant of myocarditis associated with hepatitis C-virus infection. Circulation 1997; 96: 22-4.
41. Yan FM, Chen AS, Hao F, et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2000; 6: 805-11.
42. Omura T, Yoshiyama M, Hayashi T, et al. Core protein of hepatitis C virus induces cardiomyopathy. Circ Res 2005; 96: 148-50.
43. Prati D, Poli F, Farma E, et al. Multicenter study on hepatitis C virus infection in patients with dilated cardiomyopathy. North Italy Transplant Program (NITP). J Med Virol 1999; 58: 116-20.
44. Dalekos GN, Achenbach K, Christodoulou D, et al. Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection. Heart 1998; 80: 270-5.